JP2024518429A5 - - Google Patents
Info
- Publication number
- JP2024518429A5 JP2024518429A5 JP2023568486A JP2023568486A JP2024518429A5 JP 2024518429 A5 JP2024518429 A5 JP 2024518429A5 JP 2023568486 A JP2023568486 A JP 2023568486A JP 2023568486 A JP2023568486 A JP 2023568486A JP 2024518429 A5 JP2024518429 A5 JP 2024518429A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- compound
- solvent
- diffraction pattern
- radiation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163187125P | 2021-05-11 | 2021-05-11 | |
| US63/187,125 | 2021-05-11 | ||
| PCT/US2022/028606 WO2022240886A1 (en) | 2021-05-11 | 2022-05-10 | Solid forms of salts of 4-[5-[(3s)-3-aminopyrrolidine-1-carbonyl]-2-[2-fluoro-4-(2-hydroxy-2-ethylpropyl)phenyl]phenyl]-2-fluoro-benzonitrile |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024518429A JP2024518429A (ja) | 2024-05-01 |
| JP2024518429A5 true JP2024518429A5 (https=) | 2025-05-20 |
Family
ID=81854861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023568486A Pending JP2024518429A (ja) | 2021-05-11 | 2022-05-10 | ４－［５－［（３ｓ）－３－アミノピロリジン－１－カルボニル］－２－［２－フルオロ－４－（２－ヒドロキシ－２－エチルプロピル）フェニル］フェニル］－２－フルオロ－ベンゾニトリルの塩の固体形態 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240228438A1 (https=) |
| EP (1) | EP4337638A1 (https=) |
| JP (1) | JP2024518429A (https=) |
| CN (1) | CN117769540A (https=) |
| TW (1) | TW202308991A (https=) |
| WO (1) | WO2022240886A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250295660A1 (en) | 2022-05-09 | 2025-09-25 | Oryzon Genomics, S.A. | Methods of treating nf1-mutant tumors using lsd1 inhibitors |
| EP4522136A1 (en) | 2022-05-09 | 2025-03-19 | Oryzon Genomics, S.A. | Methods of treating malignant peripheral nerve sheath tumor (mpnst) using lsd1 inhibitors |
| CN120529900A (zh) | 2022-11-24 | 2025-08-22 | 奥莱松基因组股份有限公司 | 用于治疗癌症的LSD1抑制剂和Menin抑制剂的组合 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2013005165A (es) * | 2010-11-10 | 2013-07-05 | Theravance Inc | Formas cristalinas de un acido alcoxiimidazol-1-ilmetil bifenil carboxilico. |
| CA2991020A1 (en) * | 2015-07-07 | 2017-01-12 | Japan Tobacco Inc. | Method for producing 7h-pyrrolo[2, 3-d]pyrimidine derivative and intermediate thereof |
| EP3381896B1 (en) * | 2015-11-27 | 2023-01-18 | Taiho Pharmaceutical Co., Ltd. | Biphenyl compound or salt thereof |
| AU2017385958B2 (en) * | 2016-12-28 | 2021-12-02 | Tonix Pharma Holdings Limited | Tianeptine oxalate salts and polymorphs |
| WO2021095835A1 (en) * | 2019-11-13 | 2021-05-20 | Taiho Pharmaceutical Co., Ltd. | Novel salt of terphenyl compound |
-
2022
- 2022-05-10 EP EP22726922.2A patent/EP4337638A1/en not_active Withdrawn
- 2022-05-10 CN CN202280034492.9A patent/CN117769540A/zh active Pending
- 2022-05-10 WO PCT/US2022/028606 patent/WO2022240886A1/en not_active Ceased
- 2022-05-10 US US18/560,360 patent/US20240228438A1/en active Pending
- 2022-05-10 JP JP2023568486A patent/JP2024518429A/ja active Pending
- 2022-05-10 TW TW111117524A patent/TW202308991A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024518429A5 (https=) | ||
| JP2023554492A5 (https=) | ||
| CA2632283C (en) | Polymorphs of a c-met/hgfr inhibitor | |
| WO2022258040A1 (zh) | 用于tead抑制剂的杂环化合物 | |
| JP2022507251A5 (https=) | ||
| WO2025045106A1 (zh) | 一种PI3Kα抑制剂及其用途 | |
| WO2016011979A1 (zh) | 2，4-二取代7H-吡咯并[2，3-d]嘧啶衍生物、其制法与医药上的用途 | |
| CN109937200B (zh) | 一种苯并呋喃类衍生物游离碱的晶型及制备方法 | |
| JP2022523368A5 (https=) | ||
| IL298966A (en) | Bicyclic compound and application thereof | |
| WO2016124067A1 (zh) | 一种周期素依赖性蛋白激酶抑制剂的羟乙基磺酸盐、其结晶形式及制备方法 | |
| JP2022534788A5 (https=) | ||
| DK150483B (da) | Analogifremgangsmaade til fremstilling af trans-3-(4-oxo-4h-quinazolin-3-yl)-2-propensyrederivater eller salte deraf med farmaceutisk acceptablesyrer | |
| CN110862389A (zh) | 一种阿哌沙班晶型的制备方法 | |
| KR100467668B1 (ko) | 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물 | |
| JP2023518399A5 (https=) | ||
| JP2022540678A5 (https=) | ||
| JP5378499B2 (ja) | 微小管形成阻害剤として有用なベンゾフェノンチアゾール誘導体及びその製造方法 | |
| WO2002006249A1 (en) | Method for producing 1-substituted-1,2,3-triazole derivative | |
| WO2020156162A1 (zh) | Mek抑制剂及其在医药上的应用 | |
| JP2020083892A5 (https=) | ||
| KR100470075B1 (ko) | 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물 | |
| JP7618575B2 (ja) | Ｎ－（５－（（４－エチルピペラジン－１－イル）メチル）ピリジン－２－イル）－５－フルオロ－４－（３－イソプロピル－２－メチル－２ｈ－インダゾール－５－イル）ピリミジン－２－アミンおよびその塩の結晶形態および非晶質形態、ならびにその製造方法および治療的使用 | |
| CN107226807B (zh) | 端锚聚合酶抑制剂 | |
| JP2024529533A5 (https=) |